273 related articles for article (PubMed ID: 11966861)
21. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
[TBL] [Abstract][Full Text] [Related]
23. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
Dodick DW
Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
[TBL] [Abstract][Full Text] [Related]
24. Aspirin with or without an antiemetic for acute migraine headaches in adults.
Kirthi V; Derry S; Moore RA
Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD008041. PubMed ID: 23633350
[TBL] [Abstract][Full Text] [Related]
25. Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial.
Diener HC; Gendolla A; Gebert I; Beneke M
Eur Neurol; 2005; 53 Suppl 1():41-8. PubMed ID: 15920337
[TBL] [Abstract][Full Text] [Related]
26. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
[TBL] [Abstract][Full Text] [Related]
27. Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan.
Allais G; Acuto G; Benedetto C; D'Andrea G; Grazzi L; Manzoni GC; Moschiano F; d'Onofrio F; Valguarnera F; Bussone G
Neurol Sci; 2010 Jun; 31 Suppl 1(Suppl 1):S115-9. PubMed ID: 20464599
[TBL] [Abstract][Full Text] [Related]
28. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD009665. PubMed ID: 22336869
[TBL] [Abstract][Full Text] [Related]
29. Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine.
Peikert A; Becker WJ; Ashford EA; Dahlof C; Hassani H; Salonen RJ
Eur J Neurol; 1999 Jan; 6(1):43-9. PubMed ID: 10209349
[TBL] [Abstract][Full Text] [Related]
30. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
[TBL] [Abstract][Full Text] [Related]
31. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
32. Predicting the response to sumatriptan: the Sumatriptan Naratriptan Aggregate Patient Database.
Christoph-Diener H; Ferrari M; Mansbach H;
Neurology; 2004 Aug; 63(3):520-4. PubMed ID: 15304585
[TBL] [Abstract][Full Text] [Related]
33. Post Hoc Subanalysis of Two Randomized, Controlled Phase 3 Trials Evaluating Diclofenac Potassium for Oral Solution: Impact of Migraine-Associated Nausea and Prior Triptan Use on Efficacy.
Lipton RB; Schmidt P; Diener HC
Headache; 2017 May; 57(5):756-765. PubMed ID: 28386945
[TBL] [Abstract][Full Text] [Related]
34. Sumatriptan (oral route of administration) for acute migraine attacks in adults.
Derry CJ; Derry S; Moore RA
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008615. PubMed ID: 22336849
[TBL] [Abstract][Full Text] [Related]
35. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
[TBL] [Abstract][Full Text] [Related]
36. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Mondell BE
Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan.
Pfaffenrath V; Cunin G; Sjonell G; Prendergast S
Headache; 1998 Mar; 38(3):184-90. PubMed ID: 9563208
[TBL] [Abstract][Full Text] [Related]
38. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
39. Comparative tolerability of treatments for acute migraine: A network meta-analysis.
Thorlund K; Toor K; Wu P; Chan K; Druyts E; Ramos E; Bhambri R; Donnet A; Stark R; Goadsby PJ
Cephalalgia; 2017 Sep; 37(10):965-978. PubMed ID: 27521843
[TBL] [Abstract][Full Text] [Related]
40. Oral sumatriptan compared with placebo in the acute treatment of migraine.
Nappi G; Sicuteri F; Byrne M; Roncolato M; Zerbini O
J Neurol; 1994 Jan; 241(3):138-44. PubMed ID: 8164015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
